Anemia of Chronic Disease Diagnosis and Management

Introduction to Anemia of Chronic Disease

The American College of Physicians recommends that a low total iron binding capacity (TIBC) combined with elevated ferritin is indicative of anemia of chronic disease, where iron is sequestered in storage sites and unavailable for red blood cell production despite adequate or elevated iron stores 1
The European Society for Medical Oncology suggests that inflammatory iron block, not iron deficiency, is the hallmark of anemia of chronic disease, characterized by reduced transferrin production by the liver during inflammatory states 1

The National Comprehensive Cancer Network states that elevated ferritin occurs because ferritin is an acute-phase reactant that rises during inflammation, infection, tissue damage, liver disease, and malignancy—independent of actual iron stores 1
The American Society of Hematology notes that inflammatory cytokines (particularly IL-6 and TNF-α) stimulate hepcidin production, which blocks iron release from reticuloendothelial macrophages and traps iron in storage sites, making it unavailable for erythropoiesis 1

The American College of Physicians recommends calculating transferrin saturation (TSAT) using the formula: (Serum Iron × 100) ÷ TIBC, to confirm iron is sequestered and unavailable for erythropoiesis (anemia of chronic disease pattern) 1
The European Society for Medical Oncology suggests assessing inflammatory markers, such as CRP and ESR, to confirm active inflammation 1

The National Comprehensive Cancer Network recommends that the treatment target is the underlying disease, NOT the elevated ferritin itself, and that iron supplementation should not be given when TSAT <20% with ferritin >300 ng/mL 1
The American Society of Hematology states that erythropoiesis-stimulating agents (ESAs) may be appropriate in specific contexts (cancer with chemotherapy, chronic kidney disease) under REMS guidelines with informed consent 2

The American Society of Nephrology notes that functional iron deficiency can occur with ferritin 100-700 ng/mL and TSAT <20%, where IV iron may still improve hemoglobin despite elevated ferritin 1
The European Renal Association recommends a trial approach of weekly IV iron (50-125 mg for 8-10 doses) to distinguish functional iron deficiency from pure inflammatory block 1